{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9178653", "DateCompleted": {"Year": "1997", "Month": "08", "Day": "05"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "326", "Issue": "1", "PubDate": {"Year": "1997", "Month": "May", "Day": "12"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Cardiac effects of isoliquiritigenin.", "Pagination": {"StartPage": "37", "EndPage": "44", "MedlinePgn": "37-44"}, "Abstract": {"AbstractText": ["The effects of isoliquiritigenin on force of contraction (Fc), L-type Ca2+ current (I(Ca)) and intracellular Ca2+ concentration ([Ca2+]i) were investigated in rat ventricular heart muscle. Isoliquiritigenin increased Fc and I(Ca) and, after longer exposure times, resting tension and [Ca2+]i. The effect of isoliquiritigenin (100 microM) on I(Ca) was diminished by Rp-cAMPS (30 microM). 1H-[1,2,4]oxa- diazolo[4,3-a]quinoxalin-1-one (50 microM) did not influence the effects of isoliquiritigenin on Fc and I(Ca). The positive inotropic effects of isoprenaline and forskolin, but not of 3-isobutyl-1-methylxanthine, were potentiated by isoliquiritigenin (100 microM). In the presence of milrinone (10 microM), no further effects of isoliquiritigenin (100 microM) on Fc and I(Ca) were observed. It is suggested that the increase in Fc and I(Ca) by isoliquiritigenin is due to an accumulation of cyclic AMP. These effects are probably unrelated to an effect of the drug on soluble guanylyl cyclase, as reported for smooth muscle, but rather due to a direct inhibition of phosphodiesterase III activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmakologisches Institut der Universit\u00e4t Mainz, Germany."}], "LastName": "Wegener", "ForeName": "J W", "Initials": "JW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nawrath", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "5S5A2Q39HX", "NameOfSubstance": "Chalcone"}, {"RegistryNumber": "B9CTI9GB8F", "NameOfSubstance": "isoliquiritigenin"}, {"RegistryNumber": "EC 1.1.1.21", "NameOfSubstance": "Aldehyde Reductase"}, {"RegistryNumber": "EC 2.7.11.11", "NameOfSubstance": "Cyclic AMP-Dependent Protein Kinases"}, {"RegistryNumber": "EC 4.6.1.2", "NameOfSubstance": "Guanylate Cyclase"}, {"RegistryNumber": "H2D2X058MU", "NameOfSubstance": "Cyclic GMP"}, {"RegistryNumber": "SY7Q814VUP", "NameOfSubstance": "Calcium"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Aldehyde Reductase"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcium"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Chalcone"}, {"QualifierName": [], "DescriptorName": "Chalcones"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Cyclic AMP-Dependent Protein Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclic GMP"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Electrophysiology"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Guanylate Cyclase"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["physiology"], "DescriptorName": "Membrane Potentials"}, {"QualifierName": ["drug effects"], "DescriptorName": "Myocardial Contraction"}, {"QualifierName": ["enzymology", "metabolism"], "DescriptorName": "Myocardium"}, {"QualifierName": [], "DescriptorName": "Patch-Clamp Techniques"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1997", "Month": "5", "Day": "12"}, {"Year": "1997", "Month": "5", "Day": "12", "Hour": "0", "Minute": "1"}, {"Year": "1997", "Month": "5", "Day": "12", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9178653", "10.1016/s0014-2999(97)00134-9", "S0014-2999(97)00134-9"]}}]}